Shawn Puri, MD
Interventional Pain Medicine · Killeen, TXNPI 1598056293
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $23,588 of the $36,800 with a category attached, or 64.1%. 34 manufacturers reported payments, led by Abbott at 38.1% of the total. Reporting peaked in 2023 at $11,146 and has fallen 79.9% since, to $2,237 in 2025.
Across 735 payments — averaging $50.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$14K
- Vertos Medical, Inc.$6K
- Omnia Medical, LLC$5K
- Nevro Corp.$2K
- SPR Therapeutics, Inc$2K
- Spinal Simplicity, LLC$1K
- plus $7K from 28 others
What the payments were for
- Consulting fees$9,90027%
- Speaking & faculty fees$840%
- Travel & lodging$3,2009%
- Food & beverage$23,58864%
- Education$180%
- Gifts$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 391 | $14,004 |
| Vertos Medical, Inc. | 17 | $5,694 |
| Omnia Medical, LLC | 2 | $4,500 |
| Nevro Corp. | 45 | $2,457 |
| SPR Therapeutics, Inc | 21 | $1,541 |
| Spinal Simplicity, LLC | 40 | $1,340 |
| Medtronic(2 entities) | 20 | $1,224 |
| Vertiflex, Inc. | 9 | $1,167 |
| Boston Scientific | 52 | $971 |
| Relievant Medsystems, Inc. | 9 | $750 |
| Pacira Therapeutics, Inc. | 20 | $541 |
| Nalu Medical, Inc. | 11 | $448 |
| Painteq LLC | 9 | $411 |
| Pfizer | 28 | $327 |
| Stryker | 2 | $229 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $197 |
| Collegium Pharmaceutical, Inc. | 8 | $156 |
| Si-bone, Inc. | 3 | $120 |
| Amgen | 1 | $118 |
| Scilex Pharmaceuticals Inc. | 7 | $115 |
| Genesys Orthopedics Systems, L.L.C. | 2 | $115 |
| Biodelivery Sciences International, Inc. | 4 | $58 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Zyla Life Sciences, Inc. | 3 | $39 |
| Daiichi Sankyo Inc. | 3 | $39 |
| Sentynl Therapeutics, Inc. | 3 | $38 |
| Forte Bio-pharma LLC | 1 | $35 |
| Averitas Pharma Inc. | 1 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Valinor Pharma, LLC | 1 | $18 |
| AbbVie | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $13 |
| Foundation Fusion Solutions, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$5,469
- PROCLAIM$5,101
- Intracept$1,904
- SPRINT PNS System$1,111
- Superion ISS$893
- OCTRODE$844
- HA MINUTEMAN G3-R$769
- Senza$762
- Omnia$515
- Senza Spinal Cord Stimulation System$422
- RAYOS$355
- VANTA ADAPTIVESTIM$304
- Nalu Neurostimulation System$257
- Proclaim Family of SCS IPGs$248
- SACROILIAC JOINT FUSION SYSTEM$210
- WaveWriter Alpha Prime 16$155
- CD HORIZON SPINAL SYSTEM$130
- Zilretta$122
- Vanta$120
- ETERNA$119
How this compares
$36,800 in reported general payments places this provider in the 85th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 61 | $44,755 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 783 | $17,947 |
| Xtampza ErOxycodone Myristate | 22 | $9,392 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 246 | $6,125 |
| LinzessLinaclotide | 11 | $5,319 |
| Buprenorphine | 17 | $3,179 |
| Lidocaine | 36 | $3,178 |
| Gabapentin | 223 | $2,820 |
| Pregabalin | 119 | $2,458 |
| Tramadol Hcl ErTramadol Hcl | 22 | $1,493 |
| Tramadol Hcl | 213 | $1,332 |
| Tizanidine Hcl | 179 | $1,310 |
| Morphine Sulfate ErMorphine Sulfate | 69 | $1,274 |
| Oxycodone Hcl | 79 | $812 |
| Duloxetine Hcl | 41 | $769 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $156 | $54,14783 claims |
| AbbVieLinzess | $16 | $5,31911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Killeen
- Pankaj MehtaKilleen$2.1M
- Kristian DelgadoKilleen$30K
- Bradley CullingKilleen$24K
- Gabor RaczLubbock$3M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.